Researchers say finding a single gene that harbors genetic variants responsible for tens of thousands of patients with a rare ...

Researchers say NADINA trial is the first trial within the oncological field that researched a purely immune-therapeutic and personalized treatment.

A new study led by researchers at the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) demonstrates a drug approved to treat certain autoimmune ...

Thermo Fisher Scientific reports that the facility enables customers to meet clinical trial requirements regardless of scale or phase.

Scientists developed a Cervix Chip to replicate tissue and microbiome interactions and offering a powerful new tool for ...

Unlike CRISPR 1.0, which hacks through DNA, CRISPR 2.0 is capable of surgical incisions, making it suitable for a broader ...

Super-resolution fluorescence microscopy and specific labeling reveals the nanoscopic organization of viral replication ...

Study shows that a common class of antifungals works by causing fungal pathogens to launch self-destructive cellular pathways ...

Mirus Bio describes an enhancer that is simple to use, easily integrates into existing workflows, and produces high-quality ...

Industry experts discuss the prospects for microbiome therapeutics beyond those relying on donor materials to treat recurrent ...

More biotherapeutics can be squeezed out of cells with nondestructive monitoring, in silico modeling, and optimized fluid ...

Combining multiomics data provides more information to identify biological drivers, opening up opportunities to address more ...